Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab

por Hoda, Daanish, Simon, George R, Garrett, Christopher R
Publicado 2008

Recent Advances in Targetable Therapeutics in Metastatic Non-Squamous NSCLC

por Bansal, Pranshu, Osman, Diaa, Gan, Gregory N., Simon, George R., Boumber, Yanis
Publicado 2016

Recent Advances in Immunotherapy in Metastatic NSCLC

por Bansal, Pranshu, Osman, Diaa, Gan, Gregory N., Simon, George R., Boumber, Yanis
Publicado 2016

Indoleamine 2,3-dioxygenase activity and clinical outcome following induction chemotherapy and concurrent chemoradiation in Stage III non-small cell lung cancer

por Creelan, Ben C., Antonia, Scott, Bepler, Gerold, Garrett, Timothy J., Simon, George R., Soliman, Hatem H.
Publicado 2013

Molecular pathways and therapeutic targets in lung cancer

por Shtivelman, Emma, Hensing, Thomas, Simon, George R., Dennis, Phillip A., Otterson, Gregory A., Bueno, Raphael, Salgia, Ravi
Publicado 2014

Epidermal growth factor receptor (EGFR) mutations are exceptionally rare in thyroid transcription factor (TTF-1)-negative adenocarcinomas of the lung

por Somaiah, Neeta, Fidler, Mary Jo, Garrett-Mayer, Elizabeth, Wahlquist, Amy, Shirai, Keisuke, Buckingham, Lela, Hensing, Thomas, Bonomi, Philip, Simon, George R.
Publicado 2014

A Novel Classification of Lung Cancer into Molecular Subtypes

por West, Lisandra, Vidwans, Smruti J., Campbell, Nicholas P., Shrager, Jeff, Simon, George R., Bueno, Raphael, Dennis, Phillip A., Otterson, Gregory A., Salgia, Ravi
Publicado 2012

Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small ce...

por Chiappori, Alberto A., Williams, Charles C., Gray, Jhanelle E., Tanvetyanon, Tawee, Haura, Eric B., Creelan, Ben C., Thapa, Ram, Chen, Dung-Tsa, Simon, George R., Bepler, Gerold, Gabrilovich, Dmitry I., Antonia, Scott J.
Publicado 2018

A Phase II Trial of Alisertib (MLN8237) in Salvage Malignant Mesothelioma

por Gay, Carl M., Zhou, Yanhong, Lee, J. Jack, Tang, Xi Ming, Lu, Wei, Wistuba, Ignacio I., Ferrarotto, Renata, Gibbons, Don L., Glisson, Bonnie S., Kies, Merrill S., Simon, George R., Heymach, John V., Tsao, Anne S.
Publicado 2020

A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors

por Simon, George R., Ilaria, Robert L., Sovak, Mika A., Williams, Charles C., Haura, Eric B., Cleverly, Ann L., Sykes, Amanda K., Wagner, Margaret M., de Alwis, Dinesh P., Slapak, Christopher A., Miller, Mary A., Spriggs, David R.
Publicado 2011

ALK: a tyrosine kinase target for cancer therapy

por Holla, Vijaykumar R., Elamin, Yasir Y., Bailey, Ann Marie, Johnson, Amber M., Litzenburger, Beate C., Khotskaya, Yekaterina B., Sanchez, Nora S., Zeng, Jia, Shufean, Md Abu, Shaw, Kenna R., Mendelsohn, John, Mills, Gordon B., Meric-Bernstam, Funda, Simon, George R.
Publicado 2017

SPACEWALK: A Remote Participation Study of ALK Resistance Leveraging Plasma Cell-Free DNA Genotyping

por Lawrence, Marissa N., Tamen, Rubii M., Martinez, Pablo, Sable-Hunt, Alicia, Addario, Tony, Barbour, Pete, Shaffer, Tristan, Hosseini, Seyed Ali, Bertucci, Caterina, Lim, Lee P., Hong, Fangxin, Michael, Kesi, Simon, George R., Riess, Jonathan W., Awad, Mark M., Oxnard, Geoffrey R.
Publicado 2021

Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies

por Hegde, Aparna, Andreev-Drakhlin, Alexander Y, Roszik, Jason, Huang, Le, Liu, Shuang, Hess, Kenneth, Cabanillas, Maria, Hu, Mimi I, Busaidy, Naifa L, Sherman, Steven I, Dadu, Ramona, Grubbs, Elizabeth G, Ali, Siraj M, Lee, Jessica, Elamin, Yasir Y, Simon, George R, Blumenschein, Jr, George R, Papadimitrakopoulou, Vassiliki A, Hong, David, Meric-Bernstam, Funda, Heymach, John, Subbiah, Vivek
Publicado 2020